Refractory Lymphoplasmacytic Lymphoma
generalA lymphoplasmacytic lymphoma that is resistant to treatment.
5
Centers
5
Active Trials
$59M
Cancer Funding
Specific Cancer Types(1)
| Name | Centers |
|---|---|
| Refractory Waldenstrom Macroglobulinemia | 1 |
Top Centers for Refractory Lymphoplasmacytic Lymphoma(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 79.4 |
| 2 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 56.9 |
| 3 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 56.9 |
| 4 | University of Illinois Cancer CenterChicago, IL Active Research Program | 56.9 |
| 5 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL | — |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →